Valicenti Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Valicenti Advisory Services's AZN Position: Q3 2026 in Review
Valicenti Advisory Services increased its AstraZeneca (AZN) stake by 6.8% in Q3 2026, buying an estimated $392K and bringing the position to 36,839 shares worth $5.95M. The position accounts for 1.12% of the portfolio, ranked #26.
Valicenti Advisory Services first reported a position in AZN in Q1 2024 and has held it in 11 quarters since. The position peaked at $6.54M in Q2 2026. 441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Valicenti Advisory Services held 36,839 shares of AstraZeneca worth $5.95M as of Q3 2026.
- Valicenti Advisory Services bought 2,354 AstraZeneca shares in Q3 2026, an estimated $392K.
- AstraZeneca made up 1.12% of Valicenti Advisory Services's portfolio in Q3 2026, its #26 holding.
- Valicenti Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 11 quarters since.
- Valicenti Advisory Services's AstraZeneca position peaked at $6.54M in Q2 2026.
- 441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Valicenti Advisory Services's 13F filing for Q3 2026, filed 23 Oct 2026.